Prosper's intentions to merge were just a bluff say analysts

Stock-listed pharmaceuticals wholesaler Prosper, one of the four biggest in the country, which declared it was looking for an investor, has not placed any offer worth analyzing with any of its large domestic competitors. Furthermore, none of those competitors is likely to propose a consolidation schemes first. Analysts claim that the move was merely a ploy to attract attention to prosper's shares. Prosper's competitors, Farmacol and PGF, which would be potential partners for a merger with the company, are at present taking over smaller wholesalers and may be interested in taking part in the privatization of Cefarm from Bialystok and Krakow. "'Prosper's intention was welcomed by investors and its share value jumped for a short period. However, this could be only sustained over a longer term if some confirmed information was released or the company published pleasing quarterly results," commented one analyst. (Puls Biznesu, pp. 1, 3) M.M.